Australia markets closed

WELL Health Technologies Corp. (WELL.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
3.9600+0.3800 (+10.61%)
At close: 03:59PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 973.21M
Enterprise value 1.36B
Trailing P/E N/A
Forward P/E 16.16
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.21
Price/book (mrq)1.27
Enterprise value/revenue 1.75
Enterprise value/EBITDA 12.15

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-25.28%
S&P500 52-week change 325.59%
52-week high 35.5500
52-week low 33.4100
50-day moving average 33.7590
200-day moving average 33.9922

Share statistics

Avg vol (3-month) 3943.44k
Avg vol (10-day) 3871.24k
Shares outstanding 5245.76M
Implied shares outstanding 6245.63M
Float 8225.68M
% held by insiders 16.84%
% held by institutions 14.57%
Shares short (30 Apr 2024) 42.41M
Short ratio (30 Apr 2024) 43.84
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.98%
Shares short (prior month 28 Mar 2024) 42.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.01%
Operating margin (ttm)5.24%

Management effectiveness

Return on assets (ttm)1.88%
Return on equity (ttm)2.00%

Income statement

Revenue (ttm)776.05M
Revenue per share (ttm)3.28
Quarterly revenue growth (yoy)47.70%
Gross profit (ttm)N/A
EBITDA 91.33M
Net income avi to common (ttm)82k
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)34.80%

Balance sheet

Total cash (mrq)43.42M
Total cash per share (mrq)0.18
Total debt (mrq)426.28M
Total debt/equity (mrq)50.38%
Current ratio (mrq)1.15
Book value per share (mrq)3.18

Cash flow statement

Operating cash flow (ttm)66.44M
Levered free cash flow (ttm)35.25M